ArriVent BioPharma, Inc.

AVBP Healthcare Biotechnology

In the quarter to June 2026, EPS fell 16.7% and free cash flow fell 51.5%, each against the same quarter a year earlier.

16.66 0.13 −0.77%
Market cap
$827.9M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Current Ratio
12.83 13.14 13.76 21.84 23.63
Net Debt/EBITDA
1.73 2.32 2.02 4.43 0.72
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 —
Operating CF/Net income
0.97 0.87 0.81 1.18 0.24
Capex/Depreciation
0.00 — — — —
ROE
(58.88%) (154.10%) 58.19% 55.19% 0.00%
ROA
(54.70%) (36.75%) (40.08%) (32.68%) 0.00%
ROIC
0.00% (151.95%) (5,134.22%) (207.99%) (818.42%)
Return on Tangible Assets
(54.18%) (38.38%) (46.74%) (21.18%) (125.46%)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
(4.18) (2.23) (26.08) (34.17) (17.70)
Cash per Share
8.13 6.95 70.24 127.93 52.43
Shareholders Equity per Share
7.99 8.19 70.67 136.62 57.98
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00
Book value per Share
7.99 8.19 70.67 136.62 57.98
Free Cash Flow
(160.59) (70.21) (55.84) (43.63) (12.59)
Working Capital
306.95 209.71 148.34 174.26 41.13
Net Current Asset Value
306.95 209.69 148.17 174.25 41.13
Other line items
Quick Ratio
12.06 12.67 12.94 19.54 20.51
Depreciation/Fixed assets
0.00 — — — —
Cash ROIC
(25.90%) (14.73%) (18.51%) (12.91%) (16.03%)
Accounts Payable Turnover
0.00 0.00 0.00 0.00 —
Average Days of Payables
0.00 0.00 0.00 0.00 0.00
Revenue per Share
0.00 0.00 0.00 0.00 0.00
Operating CF per Share
(4.18) (2.23) (26.08) (34.17) (17.70)
Capex per Share
0.00 0.00 0.00 0.00 0.00
Average Payables
4.86 4.16 3.81 1.69 —
Average Assets
304.06 219.02 172.97 112.94 —
Average Common Equity
282.44 52.23 (119.15) (66.88) —

Fold the line items

Columns are period end dates